Neurocrine Biosciences | 应收帐款人

Trade Debtors 更改 日
AbbVie USD 11.95B 537M 2024-03
Acadia Pharmaceuticals USD 100.08M 2.27M 2024-03
Agios Pharmaceuticals USD 3.45M 643K 2024-03
ALKERMES USD 317.08M 16.11M 2024-03
Alnylam Pharmaceuticals USD 321.38M 6.41M 2024-03
Amgen USD 6.78B 492M 2024-03
Biogen USD 2B 100.3M 2024-03
BioMarin Pharmaceutical USD 637.16M 3.46M 2024-03
Cytokinetics USD 834K 449K 2024-03
Dynavax Technologies USD 46.15M 1.62M 2024-03
Exelixis USD 240.58M 7.54M 2024-03
Gilead Sciences USD 4.67B 9M 2024-03
Halozyme Therapeutics USD 195.9M 38.31M 2024-03
Incyte USD 745.53M 1.97M 2024-03
Intra Cellular Therapies USD 131.16M 17.14M 2024-03
Ionis Pharmaceuticals USD 5.14M 92.64M 2024-03
Neurocrine Biosciences USD 450.7M 32.9M 2024-03
Pfizer USD 15.22B 219M 2024-03
Prothena USD 0 5.16M 2024-03
Regeneron Pharmaceuticals USD 5.22B 445.1M 2024-03
Repligen USD 115.77M 9.61M 2024-03
Sarepta Therapeutics USD 419.38M 65.12M 2024-03
Teva Pharmaceutical Industries USD 3.46B 48M 2024-03
Ultragenyx Pharmaceutical USD 100.25M 20.99M 2024-03
Vertex Pharmaceuticals USD 1.79B 254.5M 2024-03



Neurocrine Biosciences 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.